Kiran Shaw expresses disappointment over SEBI s ruling
Kiran Shaw expresses disappointment over SEBI s ruling
Biocon Chief Kiran Mazumdar Shaw has tweeted her displeasure about a SEBI judgement on Allegro Capital.
In its judgement, SEBI barred Allegro Capital and its MD and CEO, Kunal Kashyap, from participating in Indian security markets for one year over insider trading in the probe over Biocon s scrip movement in 2018.
Taking to Twitter, Shaw tweeted, What does MSMF (Mazumdar Shaw Medical Foundation) have to do with Biocon? The officer concerned needs to explain her convoluted hypothesis. SEBI needs to act rationally in insider trading judgements.
When a Twitter user added screenshots to point towards the relationship, Shaw replied that Mazumdar Shaw Medical Foundation had zero links to Biocon.